| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. | Blood | 2003 | 2.76 |
| 2 | Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back. | Am J Med Genet A | 2010 | 1.36 |
| 3 | Suppression of leukemia development caused by PTEN loss. | Proc Natl Acad Sci U S A | 2011 | 1.10 |
| 4 | Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation. | Hum Mutat | 2008 | 1.07 |
| 5 | De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. | J Med Genet | 2007 | 1.02 |
| 6 | Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders. | Cell Cycle | 2006 | 1.01 |
| 7 | De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features. | BMJ Case Rep | 2009 | 0.76 |